{"id":"https://openalex.org/W1978194780","doi":"https://doi.org/10.1017/s0033291710001893","title":"The heterogeneity of antipsychotic response in the treatment of schizophrenia","display_name":"The heterogeneity of antipsychotic response in the treatment of schizophrenia","alternate_titles":[],"publication_year":2010,"publication_date":"2010-10-07","ids":{"openalex":"https://openalex.org/W1978194780","doi":"https://doi.org/10.1017/s0033291710001893","mag":"1978194780","pmid":"https://pubmed.ncbi.nlm.nih.gov/20925971","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3080711"},"language":"en","primary_location":{"id":"doi:10.1017/s0033291710001893","doi":"https://doi.org/10.1017/s0033291710001893","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s0033291710001893","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/400FB626F45319294ABFF323DCFAD988/S0033291710001893a.pdf/div-class-title-the-heterogeneity-of-antipsychotic-response-in-the-treatment-of-schizophrenia-div.pdf","source":{"id":"https://openalex.org/S71144982","display_name":"Psychological Medicine","issn_l":"0033-2917","issn":["0033-2917","1469-8978"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychological Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978194780"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/400FB626F45319294ABFF323DCFAD988/S0033291710001893a.pdf/div-class-title-the-heterogeneity-of-antipsychotic-response-in-the-treatment-of-schizophrenia-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M. Case","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Case","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015085334","display_name":"Virginia L. Stauffer","orcid":"https://orcid.org/0000-0001-5301-3065","observed_orcids":["https://orcid.org/0000-0001-5301-3065"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. L. Stauffer","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011706362","display_name":"Haya Ascher\u2010Svanum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Ascher-Svanum","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108775285","display_name":"Robert R. Conley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Conley","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037602769","display_name":"Shitij Kapur","orcid":"https://orcid.org/0000-0002-2231-2924","observed_orcids":["https://orcid.org/0000-0002-2231-2924"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Kapur","raw_affiliation_strings":["Institute of Psychiatry, King's College London, UK","Psychosis Studies"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, King's College London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Psychosis Studies","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004031088","display_name":"John Michael Kane","orcid":"https://orcid.org/0000-0002-2628-9442","observed_orcids":["https://orcid.org/0000-0002-2628-9442"]},"institutions":[{"id":"https://openalex.org/I4210166545","display_name":"Zucker Hillside Hospital","ror":"https://ror.org/05vh9vp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. M. Kane","raw_affiliation_strings":["Zucker Hillside Hospital, Glen Oaks, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zucker Hillside Hospital, Glen Oaks, NY, USA","institution_ids":["https://openalex.org/I4210166545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049121567","display_name":"Sara Kollack\u2010Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Kollack-Walker","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079384242","display_name":"Jayanthi Jacob","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. Jacob","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010145606","display_name":"Bruce J. Kinon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. J. Kinon","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5079384242"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":{"value":3550,"currency":"USD","value_usd":3550},"fwci":3.2885,"has_fulltext":true,"cited_by_count":94,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91117013,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"41","issue":"6","first_page":"1291","last_page":"1300"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antipsychotic-treatment-response","display_name":"antipsychotic treatment response","score":0.8880000114440918},{"id":"https://openalex.org/keywords/treatment-response-heterogeneity","display_name":"treatment response heterogeneity","score":0.921999990940094},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8579999804496765},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.8930000066757202},{"id":"https://openalex.org/keywords/early-responders","display_name":"early responders","score":0.5230000019073486},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.5460000038146973},{"id":"https://openalex.org/keywords/endophenotypes","display_name":"endophenotypes","score":0.7419999837875366},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.7770000100135803},{"id":"https://openalex.org/keywords/growth-mixture-modeling","display_name":"growth mixture modeling","score":0.6610000133514404},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.7784057855606079},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7389695644378662},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.7209741473197937},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.668027400970459},{"id":"https://openalex.org/C187869287","wikidata":"https://www.wikidata.org/wiki/Q2032061","display_name":"Endophenotype","level":3,"score":0.5896983742713928},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5765817761421204},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5181013941764832},{"id":"https://openalex.org/C3019023267","wikidata":"https://www.wikidata.org/wiki/Q1441305","display_name":"Negative symptom","level":3,"score":0.5003581047058105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47007328271865845},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3876636326313019},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.37419646978378296},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3735102415084839},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.33770185708999634},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.16053223609924316}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1017/s0033291710001893","doi":"https://doi.org/10.1017/s0033291710001893","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s0033291710001893","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/400FB626F45319294ABFF323DCFAD988/S0033291710001893a.pdf/div-class-title-the-heterogeneity-of-antipsychotic-response-in-the-treatment-of-schizophrenia-div.pdf","source":{"id":"https://openalex.org/S71144982","display_name":"Psychological Medicine","issn_l":"0033-2917","issn":["0033-2917","1469-8978"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychological Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3080711","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3080711/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychol Med","raw_type":"Text"},{"id":"pmid:20925971","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20925971","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychological medicine","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/e404a5a3-225f-42b1-8748-89c103172282","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/e404a5a3-225f-42b1-8748-89c103172282","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case, M, Stauffer, V L, Ascher-Svanum, H, Conley, R, Kapur, S, Kane, J M, Kollack-Walker, S, Jacob, J & Kinon, B J 2011, 'The heterogeneity of antipsychotic response in the treatment of schizophrenia', Psychological Medicine, vol. 41, no. 6, pp. 1291 - 1300. https://doi.org/10.1017/S0033291710001893","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/257538","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/257538","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/48a6e65d-67f7-4888-9b5f-a3eceecea5d2","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/48a6e65d-67f7-4888-9b5f-a3eceecea5d2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Case, M G, Stauffer, V L, Ascher-Svanum, H, Conley, R, Kapur, S, Kane, J M, Kollack-Walker, S, Jacob, J & Kinon, B J 2010, 'The Heterogeneity of Antipsychotic Response in the Treatment of Schizophrenia', Biological psychiatry, vol. 67, no. 9, pp. 76S - 76S.","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/s0033291710001893","doi":"https://doi.org/10.1017/s0033291710001893","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s0033291710001893","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/400FB626F45319294ABFF323DCFAD988/S0033291710001893a.pdf/div-class-title-the-heterogeneity-of-antipsychotic-response-in-the-treatment-of-schizophrenia-div.pdf","source":{"id":"https://openalex.org/S71144982","display_name":"Psychological Medicine","issn_l":"0033-2917","issn":["0033-2917","1469-8978"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychological Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978194780.pdf","grobid_xml":"https://content.openalex.org/works/W1978194780.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W11911259","https://openalex.org/W1506609358","https://openalex.org/W1604217211","https://openalex.org/W1963949005","https://openalex.org/W1967133683","https://openalex.org/W1984250632","https://openalex.org/W1996254896","https://openalex.org/W1999689270","https://openalex.org/W2000636120","https://openalex.org/W2008062633","https://openalex.org/W2012720659","https://openalex.org/W2028799838","https://openalex.org/W2040373715","https://openalex.org/W2042626581","https://openalex.org/W2047151451","https://openalex.org/W2050173051","https://openalex.org/W2050388117","https://openalex.org/W2108553948","https://openalex.org/W2114559667","https://openalex.org/W2116594433","https://openalex.org/W2131823335","https://openalex.org/W2132980997","https://openalex.org/W2136057690","https://openalex.org/W2138792851","https://openalex.org/W2140606211","https://openalex.org/W2141478521","https://openalex.org/W2141773277","https://openalex.org/W2144234230","https://openalex.org/W2149639459","https://openalex.org/W2150461740","https://openalex.org/W2153671223","https://openalex.org/W2159155203","https://openalex.org/W2160628995","https://openalex.org/W2162441383","https://openalex.org/W2165379748","https://openalex.org/W2166514927","https://openalex.org/W2168362177","https://openalex.org/W2168578944","https://openalex.org/W2421912420","https://openalex.org/W3090293687","https://openalex.org/W4205849030","https://openalex.org/W7074072106"],"related_works":["https://openalex.org/W2022835786","https://openalex.org/W1964444879","https://openalex.org/W3093772652","https://openalex.org/W2049019621","https://openalex.org/W2001906056","https://openalex.org/W2002823976","https://openalex.org/W2160077102","https://openalex.org/W6930500311","https://openalex.org/W4220925520","https://openalex.org/W2162441383"],"abstract_inverted_index":{"BACKGROUND:":[0],"Schizophrenia":[1],"is":[2],"a":[3,74],"heterogeneous":[4],"disorder":[5,86],"in":[6,39,231],"terms":[7],"of":[8,17,34,46,51,62,79,166,225,240],"patient":[9],"response":[10,19,35,95,220,241],"to":[11,22,30,36,71,229,242],"antipsychotic":[12,37],"treatment.":[13],"Understanding":[14],"the":[15,44],"heterogeneity":[16,235],"treatment":[18,24,38,219,230,243],"may":[20,236],"help":[21],"guide":[23],"decisions.":[25],"This":[26,214,234],"study":[27,78,215],"was":[28,69,174],"undertaken":[29],"capture":[31],"inherent":[32],"patterns":[33,221],"patients":[40,47,81],"with":[41,48,82,88,117,142,204,222,244],"schizophrenia,":[42],"characterize":[43],"subgroups":[45],"similar":[49],"courses":[50],"response,":[52],"and":[53,100,153,170,185,189],"examine":[54],"illness":[55],"characteristics":[56],"at":[57,182,199],"baseline":[58,120,145],"as":[59],"possible":[60],"predictors":[61],"response.":[63],"METHOD:":[64],"Growth":[65],"mixture":[66],"modeling":[67],"(GMM)":[68],"applied":[70],"data":[72],"from":[73],"randomized,":[75],"double-blind,":[76],"12-week":[77],"628":[80],"schizophrenia":[83],"or":[84,90,227],"schizo-affective":[85],"treated":[87],"risperidone":[89],"olanzapine.":[91],"RESULTS:":[92],"Four":[93],"distinct":[94,218],"trajectories":[96],"based":[97,176,193],"on":[98,177,194,207],"Positive":[99],"Negative":[101],"Syndrome":[102],"Scale":[103],"(PANSS)":[104],"total":[105,122,147],"score":[106,123,148],"over":[107],"12":[108,200],"weeks":[109,184],"were":[110,211],"identified:":[111],"Class":[112,128,137,154],"1":[113],"(420":[114],"patients,":[115,131,140,157],"80.6%)":[116],"moderate":[118],"average":[119,144],"PANSS":[121,146],"showing":[124,133,149,159],"gradual":[125,150],"symptom":[126,135,151,161,179,196],"improvement;":[127,136,152],"2":[129,183],"(65":[130],"12.5%)":[132],"rapid":[134],"3":[138],"(24":[139],"4.6%)":[141],"high":[143],"4":[155],"(12":[156],"2.3%)":[158],"unsustained":[160],"improvement.":[162],"Latent":[163],"class":[164,209],"membership":[165,210],"early":[167,171],"responders":[168,187,226],"(ER)":[169],"non-responders":[172,191,228],"(ENR)":[173],"determined":[175],"20%":[178],"improvement":[180,197],"criteria":[181,198],"ultimate":[186,190],"(UR)":[188],"(UNR)":[192],"40%":[195],"weeks.":[201],"Baseline":[202],"factors":[203],"potential":[205],"influence":[206],"latent":[208],"identified.":[212],"CONCLUSIONS:":[213],"identified":[216],"four":[217],"predominant":[223],"representation":[224],"these":[232],"classes.":[233],"represent":[237],"discrete":[238],"endophenotypes":[239],"different":[245],"etiologic":[246],"underpinnings.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978194780","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
